(0731–0764) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Real-world Study from the Greater Paris Clinical Data Warehouse
Abstract Poster Presenter: Aïcha Kante, MD, MSc – Université Paris Cité
10:30 AM - 12:30 PM Central Time

Age and Sex Influence on Clinical Manifestations of Giant Cell Arteritis: Results from the ARTESER Registry
Abstract Poster Presenter: Delia Fernandez-Lozano, MD – Hospital Universitario y Politécnico La Fe
10:30 AM - 12:30 PM Central Time

Association Between Baseline IL-6 Levels and the Clinical Phenotype of Giant Cell Arteritis
Abstract Poster Presenter: Raquel Ugena García, MD – Hospital Universitari Germans Trias i Pujol
10:30 AM - 12:30 PM Central Time

Blocking GM-CSF receptor alpha with mavrilimumab reduces production of growth factors involved in vascular remodeling in an ex-vivo model of temporal artery culture from patients with giant-cell arteritis (GCA)
Abstract Poster Presenter: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
10:30 AM - 12:30 PM Central Time

Cerebrovascular Accidents in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study
Abstract Poster Presenter: Pranathi Bandarupalli, MD (she/her/hers) – Mercy St Vincent Medical Center
10:30 AM - 12:30 PM Central Time

Characteristics of African American vs. Non-African American Patients with Giant Cell Arteritis: A Retrospective Cohort Study
Abstract Poster Presenter: Dana Nachawati, DO – University Hospitals Cleveland Medical Center/Case Western Reserve University
10:30 AM - 12:30 PM Central Time

Characterization of patients with polymyalgia rheumatica in the ARTESER giant cell arteritis cohort
Abstract Poster Presenter: Maite Silva-Diaz, MD – Complexo Hospitalario Universitario A Coruña
10:30 AM - 12:30 PM Central Time

Diagnostic Utility of Temporal Artery Biopsy in Giant Cell Arteritis: A Single Center Experience
Abstract Poster Presenter: Wendy Perdomo, MD – Thomas Jefferson University Hospital
10:30 AM - 12:30 PM Central Time

Distinct differences between giant cell arteritis diagnosed by fluorodeoxyglucose (FDG) positron emission tomography (PET) versus temporal artery biopsy-a comparative cohort study
Abstract Poster Presenter: Sehreen Mumtaz, MD, MBBS – Mayo Clinic Florida
10:30 AM - 12:30 PM Central Time

Does The Number Of Arteries Affected At The Disease Onset Predict Relapses Of Giant Cell Arteritis?
Abstract Poster Presenter: Iztok HOLC, MD, PhD (he/him/his) – University Medical Center Maribor
10:30 AM - 12:30 PM Central Time

Effectiveness and Safety of Janus Kinase Inhibitors in Giant Cell Arteritis. Real-World Clinical Practice Study and Literature Review
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
10:30 AM - 12:30 PM Central Time

Effectiveness of Tocilizumab in strokes in patients with giant cell arteritis. Spanish multicenter study of clinical practice
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
10:30 AM - 12:30 PM Central Time

Exploring Racial Variation in the Clinical Manifestations of Giant Cell Arteritis: A Retrospective Single-Center Study
Abstract Poster Presenter: Dana Nachawati, DO – University Hospitals Cleveland Medical Center/Case Western Reserve University
10:30 AM - 12:30 PM Central Time

Fibrinogen as a biomarker in the diagnosis of giant cell arteritis and detection of flares
Abstract Poster Presenter: Jonathan Miller, MBBS BSc (Hons) MRCP (UK) PGCert (MedEd) – St Vincent's University Hospital
10:30 AM - 12:30 PM Central Time

Frequency of large vessel vasculitis in giant cell arteritis with and without adventiitis of temporal artery - Is the presence of temporal arteritis sufficient to diagnose giant cell arteritis?-
Abstract Poster Presenter: Yoichiro Akiyama, MD – Meiyo Immunology and Rheumatology Clinic
10:30 AM - 12:30 PM Central Time

Giant Cell Arteritis Relapse After Treatment with Two Months of Prednisone and 12 Months of Tocilizumab
Abstract Poster Presenter: David O'Dea, BA (he/him/his) – Massachusetts General Hospital
10:30 AM - 12:30 PM Central Time

Glucocorticoid Exposure and Comorbidity Profile in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: a multi-country cohort study
Abstract Poster Presenter: Valeria Jordan M., MD – Novartis
10:30 AM - 12:30 PM Central Time

Impact of Frailty on Mortality in GCA and PMR: A Retrospective Cohort
Abstract Poster Presenter: Fatima Hassan, MD – Medical College of Wisconsin
10:30 AM - 12:30 PM Central Time

Impact of Treatment with Upadacitinib on Biomarkers Identified by Proteomics in Giant Cell Arteritis
Abstract Poster Presenter: Lisa Christ, MD – Inselspital, University Bern, Switzerland
10:30 AM - 12:30 PM Central Time

Incidence of Ischemic Vision Loss Among Patients with Polymyalgia Rheumatica and Giant Cell Arteritis
Abstract Poster Presenter: Mary Peng, MD, BA (she/her/hers) – Medical College of Wisconsin
10:30 AM - 12:30 PM Central Time

Intravenous versus subcutaneous administration of Tocilizumab in aortitis associated with giant cell arteritis: multicenter open-label study of 196 patients
Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
10:30 AM - 12:30 PM Central Time

Is There a Seasonal Pattern in Giant Cell Arteritis? Revisiting the Evidence in a Large Monocentric Cohort of 1203 patients
Abstract Poster Presenter: Milena Bond, MD – South Tyrol Health Trust
10:30 AM - 12:30 PM Central Time

Patterns of Macrophage Polarization Induced by Serum from Patients with Giant Cell Arteritis and Takayasu’s Arteritis
Abstract Poster Presenter: Irene Carrión-Barberà, MD, PhD – University of Washington
10:30 AM - 12:30 PM Central Time

Prevalence and characteristics of subclinical Polymyalgia Rheumatica in patients with Giant Cell Arteritis
Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
10:30 AM - 12:30 PM Central Time

Prevalence and Clinical Significance of Low ESR and CRP in Giant Cell Arteritis: A Population Based Study
Abstract Poster Presenter: Eugenio De Miguel, MD;PhD – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

Real World Steroid Burden, Treatment Patterns, and Rheumatologists' Perceptions on Advanced Therapy in Giant Cell Arteritis
Abstract Poster Presenter: Anisha Dua, MD, MPH – Northwestern University
10:30 AM - 12:30 PM Central Time

Relapse rate, predictors of relapses and impact of introduction of interleukin-6-receptor inhibition on relapse rate in GCA- Data from the large REATS cohort from six vasculitis centers
Abstract Poster Presenter: Verena Schönau, MD (she/her/hers) – Universitätsklinikum Erlangen
10:30 AM - 12:30 PM Central Time

Sex Differences in Subtypes of Vascular Involvement and Clinical Manifestations in Giant Cell Arteritis
Abstract Poster Presenter: Natalia López Juanes, MD – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

Stroke Characteristics in Giant Cell Arteritis and Takayasu Arteritis: A Multicenter Cohort Study of 108 Patients
Abstract Poster Presenter: Omar Dhrif, MD – CHU Dijon Bourgogne
10:30 AM - 12:30 PM Central Time

The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis
Abstract Poster Presenter: Jean-Paul Makhzoum, MD, FRCPC, MSc, FACP – Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal
10:30 AM - 12:30 PM Central Time

The Efficacy Of Targeted Therapies In Giant Cell Arteritis: A Systematic Review and Meta-Analysis
Abstract Poster Presenter: Sema Kaymaz-Tahra, MD – Bahcesehir University Faculty of Medicine
10:30 AM - 12:30 PM Central Time

The role of Methotrexate in the treatment of Giant Cell Arteritis: data from the ARTESER registry.
Abstract Poster Presenter: Pablo Francisco Muñoz Martínez, MD – Hospital Universitario y Politécnico La Fe
10:30 AM - 12:30 PM Central Time

Tocilizumab in Giant Cell Arteritis with ischemic vs non-ischemic manifestations
Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA